Biogen Spinoff Bioverativ Is A Buy
September 20, 2017 at 10:51 AM EDT
Analysts at Argus Research turned bullish on Bioverativ Inc (NASDAQ: BIVV) as the company could establish itself as a profitable biotech ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.